Biosynex SA (FR:ALBIO) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Biosynex SA, a leading health diagnostics group, has announced its 2025 financial calendar, starting with the release of its 2024 annual revenue on January 13. The company, known for its rapid tests and molecular biology solutions, continues to expand its presence in 95 countries with a strong focus on innovation in healthcare diagnostics.
For further insights into FR:ALBIO stock, check out TipRanks’ Stock Analysis page.